Thema: US75943R1023
RLAY, US75943R1023
financial-2860753_1920.jpg - Foto: THN
Relay Therapeutics stock highlights safety case for zovegalisib
Relay Therapeutics stock drew attention after management detailed zovegalisib's safety-led development strategy at a healthcare conference. Clinical updates are next.
ad-hoc-news.de, heute 01:13 Uhr
RLAY, US75943R1023
Relay Therapeutics stock: Bank of America maintains a USD ...
Second-quarter revenue was USD 0.35 million versus USD 0.96 million expected. Relay Therapeutics stock had a USD 25.92 consensus target on October 20, 2026.
ad-hoc-news.de, 24.10.26 02:43 Uhr
RLAY, US75943R1023
H.C. Wainwright raises target for Relay Therapeutics stock ...
The October 6 filing covered 93,153 shares worth USD 1.81 million. For Relay Therapeutics stock, cash stood at USD 911 million.
ad-hoc-news.de, 16.10.26 04:57 Uhr
RLAY, US75943R1023
Relay Therapeutics officer proposes USD 1.81 million sale ...
The filing covers 93,153 shares valued at USD 1.81 million on October 6, 2026. H.C. Wainwright set a USD 29.00 target for Relay Therapeutics stock.
ad-hoc-news.de, 14.10.26 03:32 Uhr
RLAY, US75943R1023
Relay Therapeutics stock fell 3.35 percent as officer filed ...
